Compounds > (e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide
Page last updated: 2024-09-04

(e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide and jnj 17203212

(e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide has been researched along with jnj 17203212 in 1 studies

Compound Research Comparison

Studies
((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide)		Trials
((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide)		Recent Studies (post-2010)
((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide)		Studies
(jnj 17203212)		Trials
(jnj 17203212)		Recent Studies (post-2010) (jnj 17203212)
85065603

Protein Interaction Comparison

ProteinTaxonomy(e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide (IC50)jnj 17203212 (IC50)
Transient receptor potential cation channel subfamily V member 1Rattus norvegicus (Norway rat)0.059
Transient receptor potential cation channel subfamily V member 1Homo sapiens (human)0.0803

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Westaway, SM1

Reviews

1 review(s) available for (e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide and jnj 17203212

ArticleYear
The potential of transient receptor potential vanilloid type 1 channel modulators for the treatment of pain.
    Journal of medicinal chemistry, 2007, May-31, Volume: 50, Issue:11

    Topics: Analgesics; Animals; Capsaicin; Humans; Pain; TRPV Cation Channels

2007